Loading…
Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report
The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from...
Saved in:
Published in: | International medical case reports journal 2021-03, Vol.14, p.191-197 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113 |
---|---|
cites | cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113 |
container_end_page | 197 |
container_issue | |
container_start_page | 191 |
container_title | International medical case reports journal |
container_volume | 14 |
creator | Sato, Shuji Shimizu, Kazuhiro Ito, Takuro Tsubono, Masakazu Ogawa, Akihiro Sasaki, Takeshi Takahashi, Mao Noro, Mahito Shirai, Kohji |
description | The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA).
A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age.
These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI. |
doi_str_mv | 10.2147/IMCRJ.S303997 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A658252433</galeid><doaj_id>oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01</doaj_id><sourcerecordid>A658252433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</originalsourceid><addsrcrecordid>eNptUl2PEyEUnRiNu1n30VdDYuJbKwwwzPhg0m3UrVmj6a7RN8Lw0dIwMMLMmv4Vf63stu62iRBy4XLOyb1wiuIlgtMSEfZ28WW-_Dy9xhA3DXtSnCLEmgki5c-nB_uT4jylDcwDNyVD7HlxgnFdkgqS0-LPwsuoRdIKzOKgoxUOXA_WGK9TAtaD-ToGbyW4ybFrg87L5eO30XXBi7gFl9teZ6ZPNnjwQySw6PoYbrPgbzuswdIGaVejGIDwClwI50LGPdJnfmVD70Qatu_ADMxzKWCp-xCHF8UzI1zS5_t4Vnz_-OFmfjm5-vppMZ9dTSSpEJsQghEWWBmNBVWSCiMUQaqGyFSsNKhBDAsNdVvVhEAGW1mShgglKDaMIYTPisVOVwWx4X20Xa6LB2H5fSLEFRdxsNJpzlBVKkZxDWVLjIINpVVb4VaqUhID77Te77T6se20ktoPUbgj0eMbb9d8FW55LremtMkCr_cCMfwadRr4JozR5_55SRGmFDKKHlErkauy3oQsJjubJJ9VtC5pSTDOqOl_UHkq3VkZvDY2548Ibw4Iay3csE7BjUP-2nQMnOyAMoaUojYPHSLI75zJ753J987M-FeHz_KA_udD_Bf5Xt8c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2513550751</pqid></control><display><type>article</type><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</creator><creatorcontrib>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</creatorcontrib><description>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA).
A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age.
These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</description><identifier>ISSN: 1179-142X</identifier><identifier>EISSN: 1179-142X</identifier><identifier>DOI: 10.2147/IMCRJ.S303997</identifier><identifier>PMID: 33824604</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Angioplasty ; Ankle ; Anticoagulants ; arterial stiffness ; Atherosclerosis ; Blood pressure ; cardio-ankle vascular index ; Case Report ; Case reports ; Cholesterol ; chronic thromboembolic pulmonary hypertension ; Dyspnea ; Health aspects ; Heart ; Hypotension ; Medical imaging ; Pathophysiology ; Patients ; Peptides ; Pulmonary arteries ; Pulmonary hypertension ; Scintigraphy ; Smooth muscle ; Thromboembolism ; Veins & arteries ; ventricular afterload</subject><ispartof>International medical case reports journal, 2021-03, Vol.14, p.191-197</ispartof><rights>2021 Sato et al.</rights><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Sato et al. 2021 Sato et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</citedby><cites>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</cites><orcidid>0000-0002-6386-8670 ; 0000-0003-2808-2020 ; 0000-0001-9896-0939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2513550751/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2513550751?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33824604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Shuji</creatorcontrib><creatorcontrib>Shimizu, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Takuro</creatorcontrib><creatorcontrib>Tsubono, Masakazu</creatorcontrib><creatorcontrib>Ogawa, Akihiro</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Takahashi, Mao</creatorcontrib><creatorcontrib>Noro, Mahito</creatorcontrib><creatorcontrib>Shirai, Kohji</creatorcontrib><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><title>International medical case reports journal</title><addtitle>Int Med Case Rep J</addtitle><description>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA).
A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age.
These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</description><subject>Angioplasty</subject><subject>Ankle</subject><subject>Anticoagulants</subject><subject>arterial stiffness</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>cardio-ankle vascular index</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cholesterol</subject><subject>chronic thromboembolic pulmonary hypertension</subject><subject>Dyspnea</subject><subject>Health aspects</subject><subject>Heart</subject><subject>Hypotension</subject><subject>Medical imaging</subject><subject>Pathophysiology</subject><subject>Patients</subject><subject>Peptides</subject><subject>Pulmonary arteries</subject><subject>Pulmonary hypertension</subject><subject>Scintigraphy</subject><subject>Smooth muscle</subject><subject>Thromboembolism</subject><subject>Veins & arteries</subject><subject>ventricular afterload</subject><issn>1179-142X</issn><issn>1179-142X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl2PEyEUnRiNu1n30VdDYuJbKwwwzPhg0m3UrVmj6a7RN8Lw0dIwMMLMmv4Vf63stu62iRBy4XLOyb1wiuIlgtMSEfZ28WW-_Dy9xhA3DXtSnCLEmgki5c-nB_uT4jylDcwDNyVD7HlxgnFdkgqS0-LPwsuoRdIKzOKgoxUOXA_WGK9TAtaD-ToGbyW4ybFrg87L5eO30XXBi7gFl9teZ6ZPNnjwQySw6PoYbrPgbzuswdIGaVejGIDwClwI50LGPdJnfmVD70Qatu_ADMxzKWCp-xCHF8UzI1zS5_t4Vnz_-OFmfjm5-vppMZ9dTSSpEJsQghEWWBmNBVWSCiMUQaqGyFSsNKhBDAsNdVvVhEAGW1mShgglKDaMIYTPisVOVwWx4X20Xa6LB2H5fSLEFRdxsNJpzlBVKkZxDWVLjIINpVVb4VaqUhID77Te77T6se20ktoPUbgj0eMbb9d8FW55LremtMkCr_cCMfwadRr4JozR5_55SRGmFDKKHlErkauy3oQsJjubJJ9VtC5pSTDOqOl_UHkq3VkZvDY2548Ibw4Iay3csE7BjUP-2nQMnOyAMoaUojYPHSLI75zJ753J987M-FeHz_KA_udD_Bf5Xt8c</recordid><startdate>20210331</startdate><enddate>20210331</enddate><creator>Sato, Shuji</creator><creator>Shimizu, Kazuhiro</creator><creator>Ito, Takuro</creator><creator>Tsubono, Masakazu</creator><creator>Ogawa, Akihiro</creator><creator>Sasaki, Takeshi</creator><creator>Takahashi, Mao</creator><creator>Noro, Mahito</creator><creator>Shirai, Kohji</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6386-8670</orcidid><orcidid>https://orcid.org/0000-0003-2808-2020</orcidid><orcidid>https://orcid.org/0000-0001-9896-0939</orcidid></search><sort><creationdate>20210331</creationdate><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><author>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angioplasty</topic><topic>Ankle</topic><topic>Anticoagulants</topic><topic>arterial stiffness</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>cardio-ankle vascular index</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cholesterol</topic><topic>chronic thromboembolic pulmonary hypertension</topic><topic>Dyspnea</topic><topic>Health aspects</topic><topic>Heart</topic><topic>Hypotension</topic><topic>Medical imaging</topic><topic>Pathophysiology</topic><topic>Patients</topic><topic>Peptides</topic><topic>Pulmonary arteries</topic><topic>Pulmonary hypertension</topic><topic>Scintigraphy</topic><topic>Smooth muscle</topic><topic>Thromboembolism</topic><topic>Veins & arteries</topic><topic>ventricular afterload</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Shuji</creatorcontrib><creatorcontrib>Shimizu, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Takuro</creatorcontrib><creatorcontrib>Tsubono, Masakazu</creatorcontrib><creatorcontrib>Ogawa, Akihiro</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Takahashi, Mao</creatorcontrib><creatorcontrib>Noro, Mahito</creatorcontrib><creatorcontrib>Shirai, Kohji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International medical case reports journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Shuji</au><au>Shimizu, Kazuhiro</au><au>Ito, Takuro</au><au>Tsubono, Masakazu</au><au>Ogawa, Akihiro</au><au>Sasaki, Takeshi</au><au>Takahashi, Mao</au><au>Noro, Mahito</au><au>Shirai, Kohji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</atitle><jtitle>International medical case reports journal</jtitle><addtitle>Int Med Case Rep J</addtitle><date>2021-03-31</date><risdate>2021</risdate><volume>14</volume><spage>191</spage><epage>197</epage><pages>191-197</pages><issn>1179-142X</issn><eissn>1179-142X</eissn><abstract>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA).
A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age.
These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>33824604</pmid><doi>10.2147/IMCRJ.S303997</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6386-8670</orcidid><orcidid>https://orcid.org/0000-0003-2808-2020</orcidid><orcidid>https://orcid.org/0000-0001-9896-0939</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1179-142X |
ispartof | International medical case reports journal, 2021-03, Vol.14, p.191-197 |
issn | 1179-142X 1179-142X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Angioplasty Ankle Anticoagulants arterial stiffness Atherosclerosis Blood pressure cardio-ankle vascular index Case Report Case reports Cholesterol chronic thromboembolic pulmonary hypertension Dyspnea Health aspects Heart Hypotension Medical imaging Pathophysiology Patients Peptides Pulmonary arteries Pulmonary hypertension Scintigraphy Smooth muscle Thromboembolism Veins & arteries ventricular afterload |
title | Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Arterial%20Stiffness%20in%20Chronic%20Thromboembolic%20Pulmonary%20Hypertension%20Was%20Improved%20with%20Riociguat%20and%20Balloon%20Pulmonary%20Angioplasty:%20A%20Case%20Report&rft.jtitle=International%20medical%20case%20reports%20journal&rft.au=Sato,%20Shuji&rft.date=2021-03-31&rft.volume=14&rft.spage=191&rft.epage=197&rft.pages=191-197&rft.issn=1179-142X&rft.eissn=1179-142X&rft_id=info:doi/10.2147/IMCRJ.S303997&rft_dat=%3Cgale_doaj_%3EA658252433%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2513550751&rft_id=info:pmid/33824604&rft_galeid=A658252433&rfr_iscdi=true |